Interventions targeting HIV-infected risky drinkers: drops in the bottle.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 3860515)

Published in Alcohol Res Health on January 01, 2010

Authors

Jeffery H Samet1, Alexander Y Walley

Author Affiliations

1: Boston University School of Medicine, and in the Department of Social and Behavioral Sciences, Boston University School of Public Health, Boston, Massachusetts.

Articles citing this

Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age. Biol Psychiatry (2012) 1.12

Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008. Open AIDS J (2012) 1.11

Brief Intervention Decreases Drinking Frequency in HIV-Infected, Heavy Drinking Women: Results of a Randomized Controlled Trial. J Acquir Immune Defic Syndr (2015) 0.96

Interventions to reduce alcohol use among HIV-infected individuals: a review and critique of the literature. Curr HIV/AIDS Rep (2013) 0.92

HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients. Addict Sci Clin Pract (2014) 0.85

Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011. AIDS Behav (2016) 0.83

Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83

Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS (2016) 0.82

International collaboration in HIV prevention research: evidence from a research seminar in Russia. AIDS Res Hum Retroviruses (2014) 0.78

HIV and Alcohol Research Priorities of City, State, and Federal Policymakers: Results of a Delphi Study. Am J Public Health (2015) 0.75

Post-treatment drinking among HIV patients: Relationship to pre-treatment marijuana and cocaine use. Drug Alcohol Depend (2015) 0.75

Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients. Drug Alcohol Depend (2016) 0.75

Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment. J Acquir Immune Defic Syndr (2017) 0.75

Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial. J Int Assoc Provid AIDS Care (2016) 0.75

Behavioral Interventions Targeting Alcohol Use Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis. AIDS Behav (2017) 0.75

Articles cited by this

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol (1997) 11.33

Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev (2007) 10.34

Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA (1997) 8.05

Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 6.78

Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. J Consult Clin Psychol (1999) 5.45

Clinical practice. Unhealthy alcohol use. N Engl J Med (2005) 4.86

Brief intervention for medical inpatients with unhealthy alcohol use: a randomized, controlled trial. Ann Intern Med (2007) 4.73

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA (2005) 4.64

Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr (2006) 4.49

A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49

The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol (2002) 3.71

Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr (2006) 3.62

Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department. J Stud Alcohol (2001) 3.59

Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med (1998) 3.45

Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr (2007) 3.24

Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res (2004) 3.24

A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21

Identification and intervention of heavy drinking in middle-aged men: results and follow-up of 24-60 months of long-term study with randomized controls. Alcohol Clin Exp Res (1983) 3.20

Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. BMJ (2003) 3.15

Efficacy of a preventive intervention for youths living with HIV. Am J Public Health (2001) 2.89

Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med (2001) 2.81

Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr (2006) 2.78

The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up. Addiction (2002) 2.61

Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse (2001) 2.56

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res (2001) 2.39

Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr (2007) 2.38

Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res (2003) 2.32

Preventive care in the emergency department: screening and brief intervention for alcohol problems in the emergency department: a systematic review. Acad Emerg Med (2002) 2.27

Brief alcohol intervention and alcohol assessment do not influence alcohol use in injured patients treated in the emergency department: a randomized controlled clinical trial. Addiction (2007) 2.15

How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr (2003) 2.14

Brief physician- and nurse practitioner-delivered counseling for high-risk drinkers: does it work? Arch Intern Med (1999) 2.00

Randomized trial of a community-based alcohol-related HIV risk-reduction intervention for men and women in Cape Town South Africa. Ann Behav Med (2008) 1.91

Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses (2004) 1.88

A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther (2005) 1.82

HIV treatment in drug abusers: impact of alcohol use. Addict Biol (2003) 1.72

Interactive "Video Doctor" counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One (2008) 1.71

Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care (2003) 1.64

Sensation seeking and alcohol use as markers of sexual transmission risk behavior in HIV-positive men. Ann Behav Med (2002) 1.63

Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth. AIDS Educ Prev (2006) 1.62

Alcohol consumption among HIV-infected patients. J Gen Intern Med (1995) 1.62

Effectiveness of opportunistic brief interventions for problem drinking in a general hospital setting: systematic review. BMJ (2004) 1.47

Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial. J Consult Clin Psychol (2009) 1.46

A randomized controlled trial of goal choice interventions for alcohol use disorders among men who have sex with men. J Consult Clin Psychol (2007) 1.44

A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting. AIDS Care (2006) 1.41

Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.39

Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction (2003) 1.31

Sexually transmitted infections among HIV seropositive men and women. Sex Transm Infect (2000) 1.17

Effects of behavioral intervention on substance use among people living with HIV: the Healthy Living Project randomized controlled study. Addiction (2008) 1.16

Case management for substance abusers with HIV/AIDS: a randomized clinical trial. Am J Drug Alcohol Abuse (2003) 1.13

Reducing risky sexual behavior and substance use among currently and formerly homeless adults living with HIV. Am J Public Health (2008) 1.08

Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. Am J Public Health (2009) 1.05

Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antivir Ther (2009) 1.03

Brief report: maintenance of effects of motivational enhancement therapy to improve risk behaviors and HIV-related Health in a randomized controlled trial of youth living with HIV. J Pediatr Psychol (2007) 1.02

Relationship of alcohol use and sexual risk taking among hazardously drinking incarcerated women: an event-level analysis. J Stud Alcohol Drugs (2009) 1.01

Alcohol counseling reflects higher quality of primary care. J Gen Intern Med (2008) 0.98

Naltrexone inhibits alcohol-mediated enhancement of HIV infection of T lymphocytes. J Leukoc Biol (2006) 0.95

Topiramate for alcohol dependence. Ann Pharmacother (2008) 0.86

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol Alcohol (2001) 0.85

Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures. Drug Alcohol Depend (2001) 0.83

Articles by these authors

Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health (2009) 2.99

Prevention of fatal opioid overdose. JAMA (2012) 2.53

The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men. Drug Alcohol Depend (2008) 1.33

Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health (2014) 1.17

A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus (2015) 0.99

Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med (2014) 0.98

Nondisclosure of HIV infection to sex partners and alcohol's role: a Russian experience. AIDS Behav (2013) 0.94

Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care STDS (2014) 0.94

Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol (2014) 0.89

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection. AIDS Patient Care STDS (2011) 0.87

HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers. Addiction (2014) 0.87

Lessons learned from the expansion of naloxone access in Massachusetts and North Carolina. J Law Med Ethics (2015) 0.85

Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers? Drug Alcohol Depend (2013) 0.85

Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center. J Addict Med (2014) 0.84

Update in addiction medicine for the generalist. J Gen Intern Med (2010) 0.83

Overdose Education and Naloxone Rescue Kits for Family Members of Individuals Who Use Opioids: Characteristics, Motivations, and Naloxone Use. Subst Abus (2015) 0.83

Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort. AIDS Behav (2015) 0.80

Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists. J Addict Med (2016) 0.80

Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep (2017) 0.77

2012 Update in addiction medicine for the generalist. Addict Sci Clin Pract (2013) 0.76

2013 Update in addiction medicine for the generalist. Addict Sci Clin Pract (2013) 0.76

Opioid overdose fatality prevention--reply. JAMA (2013) 0.76

Preventing prescription opioid overdose deaths. J Gen Intern Med (2013) 0.75

[Commentary]Can one be an expert in addiction medicine without expertise in pain management? Addiction (2008) 0.75

Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence. Medicine (Baltimore) (2017) 0.75

Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. J Am Pharm Assoc (2003) (2017) 0.75

Mainstreaming Naloxone Through Coprescription to Patients Receiving Long-Term Opioid Therapy for Chronic Pain. Ann Intern Med (2016) 0.75